Global Anemia Therapeutics Market Research Report 2023

Report ID: 1983287 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Anemia Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Iron Deficiency Anemia
        1.2.3 Sickle Cell Anemia
        1.2.4 Pernicious Anemia
        1.2.5 Hemolytic Anemia
    1.3 Market by Application
        1.3.1 Global Anemia Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Anemia Therapeutics Market Perspective (2017-2028)
    2.2 Anemia Therapeutics Growth Trends by Region
        2.2.1 Anemia Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Anemia Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Anemia Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Anemia Therapeutics Market Dynamics
        2.3.1 Anemia Therapeutics Industry Trends
        2.3.2 Anemia Therapeutics Market Drivers
        2.3.3 Anemia Therapeutics Market Challenges
        2.3.4 Anemia Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Anemia Therapeutics Players by Revenue
        3.1.1 Global Top Anemia Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Anemia Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Anemia Therapeutics Revenue
    3.4 Global Anemia Therapeutics Market Concentration Ratio
        3.4.1 Global Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Anemia Therapeutics Revenue in 2021
    3.5 Anemia Therapeutics Key Players Head office and Area Served
    3.6 Key Players Anemia Therapeutics Product Solution and Service
    3.7 Date of Enter into Anemia Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Anemia Therapeutics Breakdown Data by Type
    4.1 Global Anemia Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Anemia Therapeutics Forecasted Market Size by Type (2023-2028)
5 Anemia Therapeutics Breakdown Data by Application
    5.1 Global Anemia Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Anemia Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Anemia Therapeutics Market Size (2017-2028)
    6.2 North America Anemia Therapeutics Market Size by Country (2017-2022)
    6.3 North America Anemia Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Anemia Therapeutics Market Size (2017-2028)
    7.2 Europe Anemia Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Anemia Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Anemia Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Anemia Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Anemia Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Anemia Therapeutics Market Size (2017-2028)
    9.2 Latin America Anemia Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Anemia Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Anemia Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Anemia Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Anemia Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Sanofi
        11.1.1 Sanofi Company Detail
        11.1.2 Sanofi Business Overview
        11.1.3 Sanofi Anemia Therapeutics Introduction
        11.1.4 Sanofi Revenue in Anemia Therapeutics Business (2017-2022)
        11.1.5 Sanofi Recent Development
    11.2 Acceleron Pharma
        11.2.1 Acceleron Pharma Company Detail
        11.2.2 Acceleron Pharma Business Overview
        11.2.3 Acceleron Pharma Anemia Therapeutics Introduction
        11.2.4 Acceleron Pharma Revenue in Anemia Therapeutics Business (2017-2022)
        11.2.5 Acceleron Pharma Recent Development
    11.3 Bayer
        11.3.1 Bayer Company Detail
        11.3.2 Bayer Business Overview
        11.3.3 Bayer Anemia Therapeutics Introduction
        11.3.4 Bayer Revenue in Anemia Therapeutics Business (2017-2022)
        11.3.5 Bayer Recent Development
    11.4 GlaxoSmithKline
        11.4.1 GlaxoSmithKline Company Detail
        11.4.2 GlaxoSmithKline Business Overview
        11.4.3 GlaxoSmithKline Anemia Therapeutics Introduction
        11.4.4 GlaxoSmithKline Revenue in Anemia Therapeutics Business (2017-2022)
        11.4.5 GlaxoSmithKline Recent Development
    11.5 Novartis
        11.5.1 Novartis Company Detail
        11.5.2 Novartis Business Overview
        11.5.3 Novartis Anemia Therapeutics Introduction
        11.5.4 Novartis Revenue in Anemia Therapeutics Business (2017-2022)
        11.5.5 Novartis Recent Development
    11.6 Pieris Pharmaceuticals
        11.6.1 Pieris Pharmaceuticals Company Detail
        11.6.2 Pieris Pharmaceuticals Business Overview
        11.6.3 Pieris Pharmaceuticals Anemia Therapeutics Introduction
        11.6.4 Pieris Pharmaceuticals Revenue in Anemia Therapeutics Business (2017-2022)
        11.6.5 Pieris Pharmaceuticals Recent Development
    11.7 AMAG Pharmaceuticals
        11.7.1 AMAG Pharmaceuticals Company Detail
        11.7.2 AMAG Pharmaceuticals Business Overview
        11.7.3 AMAG Pharmaceuticals Anemia Therapeutics Introduction
        11.7.4 AMAG Pharmaceuticals Revenue in Anemia Therapeutics Business (2017-2022)
        11.7.5 AMAG Pharmaceuticals Recent Development
    11.8 Daiichi Sankyo
        11.8.1 Daiichi Sankyo Company Detail
        11.8.2 Daiichi Sankyo Business Overview
        11.8.3 Daiichi Sankyo Anemia Therapeutics Introduction
        11.8.4 Daiichi Sankyo Revenue in Anemia Therapeutics Business (2017-2022)
        11.8.5 Daiichi Sankyo Recent Development
    11.9 Galenica
        11.9.1 Galenica Company Detail
        11.9.2 Galenica Business Overview
        11.9.3 Galenica Anemia Therapeutics Introduction
        11.9.4 Galenica Revenue in Anemia Therapeutics Business (2017-2022)
        11.9.5 Galenica Recent Development
    11.10 Pharmacosmos
        11.10.1 Pharmacosmos Company Detail
        11.10.2 Pharmacosmos Business Overview
        11.10.3 Pharmacosmos Anemia Therapeutics Introduction
        11.10.4 Pharmacosmos Revenue in Anemia Therapeutics Business (2017-2022)
        11.10.5 Pharmacosmos Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Anemia Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Iron Deficiency Anemia
    Table 3. Key Players of Sickle Cell Anemia
    Table 4. Key Players of Pernicious Anemia
    Table 5. Key Players of Hemolytic Anemia
    Table 6. Global Anemia Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Anemia Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Anemia Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Anemia Therapeutics Market Share by Region (2017-2022)
    Table 10. Global Anemia Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Anemia Therapeutics Market Share by Region (2023-2028)
    Table 12. Anemia Therapeutics Market Trends
    Table 13. Anemia Therapeutics Market Drivers
    Table 14. Anemia Therapeutics Market Challenges
    Table 15. Anemia Therapeutics Market Restraints
    Table 16. Global Anemia Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Anemia Therapeutics Market Share by Players (2017-2022)
    Table 18. Global Top Anemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anemia Therapeutics as of 2021)
    Table 19. Ranking of Global Top Anemia Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Anemia Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Anemia Therapeutics Product Solution and Service
    Table 23. Date of Enter into Anemia Therapeutics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Anemia Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Anemia Therapeutics Revenue Market Share by Type (2017-2022)
    Table 27. Global Anemia Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Anemia Therapeutics Revenue Market Share by Type (2023-2028)
    Table 29. Global Anemia Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Anemia Therapeutics Revenue Market Share by Application (2017-2022)
    Table 31. Global Anemia Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Anemia Therapeutics Revenue Market Share by Application (2023-2028)
    Table 33. North America Anemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Anemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Anemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Anemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Anemia Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Anemia Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Anemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Anemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Anemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Anemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Sanofi Company Detail
    Table 44. Sanofi Business Overview
    Table 45. Sanofi Anemia Therapeutics Product
    Table 46. Sanofi Revenue in Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 47. Sanofi Recent Development
    Table 48. Acceleron Pharma Company Detail
    Table 49. Acceleron Pharma Business Overview
    Table 50. Acceleron Pharma Anemia Therapeutics Product
    Table 51. Acceleron Pharma Revenue in Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 52. Acceleron Pharma Recent Development
    Table 53. Bayer Company Detail
    Table 54. Bayer Business Overview
    Table 55. Bayer Anemia Therapeutics Product
    Table 56. Bayer Revenue in Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 57. Bayer Recent Development
    Table 58. GlaxoSmithKline Company Detail
    Table 59. GlaxoSmithKline Business Overview
    Table 60. GlaxoSmithKline Anemia Therapeutics Product
    Table 61. GlaxoSmithKline Revenue in Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 62. GlaxoSmithKline Recent Development
    Table 63. Novartis Company Detail
    Table 64. Novartis Business Overview
    Table 65. Novartis Anemia Therapeutics Product
    Table 66. Novartis Revenue in Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 67. Novartis Recent Development
    Table 68. Pieris Pharmaceuticals Company Detail
    Table 69. Pieris Pharmaceuticals Business Overview
    Table 70. Pieris Pharmaceuticals Anemia Therapeutics Product
    Table 71. Pieris Pharmaceuticals Revenue in Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 72. Pieris Pharmaceuticals Recent Development
    Table 73. AMAG Pharmaceuticals Company Detail
    Table 74. AMAG Pharmaceuticals Business Overview
    Table 75. AMAG Pharmaceuticals Anemia Therapeutics Product
    Table 76. AMAG Pharmaceuticals Revenue in Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 77. AMAG Pharmaceuticals Recent Development
    Table 78. Daiichi Sankyo Company Detail
    Table 79. Daiichi Sankyo Business Overview
    Table 80. Daiichi Sankyo Anemia Therapeutics Product
    Table 81. Daiichi Sankyo Revenue in Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 82. Daiichi Sankyo Recent Development
    Table 83. Galenica Company Detail
    Table 84. Galenica Business Overview
    Table 85. Galenica Anemia Therapeutics Product
    Table 86. Galenica Revenue in Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 87. Galenica Recent Development
    Table 88. Pharmacosmos Company Detail
    Table 89. Pharmacosmos Business Overview
    Table 90. Pharmacosmos Anemia Therapeutics Product
    Table 91. Pharmacosmos Revenue in Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 92. Pharmacosmos Recent Development
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Anemia Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Iron Deficiency Anemia Features
    Figure 3. Sickle Cell Anemia Features
    Figure 4. Pernicious Anemia Features
    Figure 5. Hemolytic Anemia Features
    Figure 6. Global Anemia Therapeutics Market Share by Application in 2021 & 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Others Case Studies
    Figure 10. Anemia Therapeutics Report Years Considered
    Figure 11. Global Anemia Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Anemia Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Anemia Therapeutics Market Share by Region: 2021 VS 2028
    Figure 14. Global Anemia Therapeutics Market Share by Players in 2021
    Figure 15. Global Top Anemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anemia Therapeutics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Anemia Therapeutics Revenue in 2021
    Figure 17. North America Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Anemia Therapeutics Market Share by Country (2017-2028)
    Figure 19. United States Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Anemia Therapeutics Market Share by Country (2017-2028)
    Figure 23. Germany Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Anemia Therapeutics Market Share by Region (2017-2028)
    Figure 31. China Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Anemia Therapeutics Market Share by Country (2017-2028)
    Figure 39. Mexico Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Anemia Therapeutics Market Share by Country (2017-2028)
    Figure 43. Turkey Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Sanofi Revenue Growth Rate in Anemia Therapeutics Business (2017-2022)
    Figure 46. Acceleron Pharma Revenue Growth Rate in Anemia Therapeutics Business (2017-2022)
    Figure 47. Bayer Revenue Growth Rate in Anemia Therapeutics Business (2017-2022)
    Figure 48. GlaxoSmithKline Revenue Growth Rate in Anemia Therapeutics Business (2017-2022)
    Figure 49. Novartis Revenue Growth Rate in Anemia Therapeutics Business (2017-2022)
    Figure 50. Pieris Pharmaceuticals Revenue Growth Rate in Anemia Therapeutics Business (2017-2022)
    Figure 51. AMAG Pharmaceuticals Revenue Growth Rate in Anemia Therapeutics Business (2017-2022)
    Figure 52. Daiichi Sankyo Revenue Growth Rate in Anemia Therapeutics Business (2017-2022)
    Figure 53. Galenica Revenue Growth Rate in Anemia Therapeutics Business (2017-2022)
    Figure 54. Pharmacosmos Revenue Growth Rate in Anemia Therapeutics Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
Acceleron Pharma
Bayer
GlaxoSmithKline
Novartis
Pieris Pharmaceuticals
AMAG Pharmaceuticals
Daiichi Sankyo
Galenica
Pharmacosmos
Frequently Asked Questions
Anemia Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Anemia Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Anemia Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports